跳至主導覽
跳至搜尋
跳過主要內容
臺北醫學大學 首頁
說明與常見問題
English
中文
首頁
專家檔案
研究單位
專案
研究成果
資料集
活動
按專業知識、姓名或所屬機構搜尋
公共衛生學院
臺北醫學大學
電話
+886-2-2736-1661 Ext. 6501 to 6503
電子郵件
[email protected]
網站
http://cphn.tmu.edu.tw/
郵寄地址
在地圖上顯示
No. 250 Wu-Xing Street
11031
Taipei
概覽
指紋
網路
專家檔案
(57)
專案
(847)
研究成果
(5086)
資料集
(160)
活動
(1)
指紋
查看啟用 公共衛生學院 的研究主題。這些主題標籤來自此機構會員的作品。共同形成了獨特的指紋。
排序方式
重量
按字母排序
Medicine and Dentistry
Meta-Analysis
100%
Systematic Review
61%
Randomized Controlled Trial
57%
Cohort Analysis
55%
Apoplexy
47%
Disease
43%
Odds Ratio
41%
Malignant Neoplasm
33%
Injury
32%
Breast Cancer
30%
Prevalence
30%
Hazard Ratio
29%
Infection
24%
Diabetes
21%
Traumatic Brain Injury
19%
Logistic Regression Analysis
18%
Chronic Kidney Disease
17%
Brain Ischemia
17%
Neoplasm
17%
Body Mass Index
16%
Programmed Cell Death
16%
Cancer Cell
16%
Urinary System
15%
Diabetes Mellitus
15%
COVID-19
15%
Medicine
14%
Symptom
14%
Cross Sectional Study
14%
Health Care Cost
13%
Disability
13%
Drug Therapy
12%
Proportional Hazards Model
12%
Cardiovascular Disease
12%
Rehabilitation Engineering
12%
Health Care
12%
Quality of Life
11%
Biological Marker
11%
Maturity Onset Diabetes of the Young
11%
Lung Cancer
11%
Case-Control Study
11%
Childbirth
11%
Particular Matter 2.5
11%
Mortality Rate
11%
Metastatic Carcinoma
11%
Public Health
10%
Hepatocellular Carcinoma
10%
In Vitro
10%
Multidrug Resistant Tuberculosis
10%
Ischemic Heart Disease
10%
Middle Age
10%
Global Disease Burden
10%
Methylation
10%
Retrospective Cohort Study
10%
Chronic Obstructive Pulmonary Disease
9%
Computer Assisted Tomography
9%
Cancer Risk
9%
Health Survey
9%
Blood Pressure
9%
Adverse Event
9%
Diagnosis
9%
Outpatient
8%
Adolescent
8%
Atmospheric Aerosol
8%
Human Immunodeficiency Virus
8%
Cesarean Section
7%
Survival Rate
7%
Emergency Department
7%
Cardiovascular System
7%
Surgeon
7%
Cytotoxicity
7%
Asthma
7%
Cohort Effect
7%
Cigarette Smoking
7%
Dietary Pattern
7%
Surgery
7%
Supplementation
7%
Metabolic Syndrome
7%
Long-Term Care
7%
Lung Tuberculosis
7%
Kidney Function
6%
Random Effects Model
6%
Recurrent Disease
6%
Kawasaki Disease
6%
Network Meta-Analysis
6%
Severe Acute Respiratory Syndrome Coronavirus 2
6%
Anemia
6%
Transitional Cell Carcinoma
6%
Signal Transduction
6%
Closed Head Injury
6%
Population
6%
Magnetic Resonance Imaging
6%
Smoking
6%
Colorectal Cancer
6%
Overall Survival
5%
Premature Labor
5%
Prospective Cohort Study
5%
Hemodialysis
5%
Glioblastoma
5%
Obstructive Sleep Apnea
5%
Cancer
5%
Pharmacology, Toxicology and Pharmaceutical Science
Cohort Study
68%
Malignant Neoplasm
61%
Disease
59%
Randomized Controlled Trial
42%
Mouse
34%
Prevalence
30%
Inflammation
29%
Injury
28%
Breast Cancer
27%
Neoplasm
27%
Infection
22%
Chronic Kidney Failure
20%
Reactive Oxygen Metabolite
20%
Liver Cell Carcinoma
19%
Diabetes Mellitus
19%
Nitric Oxide
18%
Cytotoxicity
18%
Cardiovascular Disease
18%
Lipopolysaccharide
16%
Biological Marker
16%
Brain Ischemia
15%
Adverse Event
15%
Traumatic Brain Injury
15%
Transitional Cell Carcinoma
15%
Comorbidity
14%
Lung Cancer
14%
Cyclooxygenase 2
14%
Case-Control Study
14%
Antioxidant
13%
Chronic Obstructive Lung Disease
13%
Tumor Necrosis Factor
13%
Protein P53
13%
Caspase 3
12%
Glioblastoma
11%
Chemotherapy
11%
Inducible Nitric Oxide Synthase
11%
Colon Cancer
11%
Heme Oxygenase 1
11%
Hemodialysis
11%
Colorectal Cancer
10%
Mortality Rate
10%
Cigarette Smoking
10%
Symptom
10%
Vaccination Policy
10%
Sleep Disordered Breathing
10%
Well Water
10%
Ischemic Heart Disease
10%
Non Insulin Dependent Diabetes Mellitus
10%
Phosphotransferase
9%
Survival Rate
9%
Rheumatoid Arthritis
9%
Long Term Exposure
9%
Nicotinic Receptor
9%
Anti-Inflammatory Drug
9%
Epidermal Growth Factor Receptor
8%
Mitogen Activated Protein Kinase
8%
Bladder Cancer
8%
Western Blot
8%
Hepatitis C Virus
8%
Asthma
8%
Glutathione
8%
Carcinogenesis
7%
Global Disease Burden
7%
HIV
7%
Overall Survival
7%
Interleukin 6
7%
Placebo
7%
All Cause Mortality
7%
Low Birth Weight
7%
Head Injury
7%
Prostaglandin E2
7%
Polycyclic Aromatic Hydrocarbon
7%
Cytokine
7%
Parkinson's Disease
7%
Hepatitis C
7%
Metabolic Syndrome X
7%
Antivirus Agent
7%
Clinical Trial
7%
Dose-Response Relationship
7%
Hyperlipidemia
7%
Combination Therapy
7%
Recurrent Disease
6%
Observational Study
6%
Ethanol
6%
Multi-Drug-Resistant Tuberculosis
6%
12-O-Tetradecanoylphorbol-13-Acetate
6%
Antiinflammatory Activity
6%
Liver Cancer
6%
Quercetin
6%
Proton Pump Inhibitor
6%
C Reactive Protein
6%
Leukemia
6%
Rifampicin
6%
Mouse Model
6%
Metastasis
5%
Cell Viability
5%
Carotid Atherosclerosis
5%
Triacylglycerol
5%
Antiinfective Agent
5%
Spinal Cord Injury
5%
Nursing and Health Professions
Meta Analysis
72%
Confidence Interval
71%
Systematic Review
42%
Odds Ratio
41%
Injury
31%
Disease
31%
Cohort Analysis
31%
Traumatic Brain Injury
27%
Quality of Life
27%
Prevalence
26%
World Health Organization
23%
Cross-Sectional Study
21%
National Health Insurance
21%
Logistic Regression Analysis
21%
Rehabilitation Engineering
20%
Disability
17%
Hazard Ratio
16%
Symptom
16%
Drug Therapy
15%
Breast Cancer
15%
Health Service
14%
Hospital
12%
Health Care Personnel
12%
Practice Guideline
11%
Outpatient
11%
Comorbidity
10%
Human Immunodeficiency Virus
10%
Malignant Neoplasm
10%
Mortality Rate
10%
Long Term Care
10%
Health Survey
10%
Health Literacy
10%
Case-Control Study
10%
Head Injury
10%
Medline
9%
Pilot Study
9%
Cochrane Library
9%
Adolescent
9%
Emergency Ward
9%
Health Status
9%
Diabetes Mellitus
9%
Psychometry
8%
Cigarette Filter
8%
Spinal Cord Injury
8%
Infection
8%
Supplementation
7%
Cardiovascular Disease
7%
Body Mass
7%
Chronic Kidney Failure
7%
Teaching Hospital
7%
Self Care
7%
Independent Practice Association
7%
Mental Health
7%
Gender Difference
7%
Metabolic Syndrome X
6%
Receiver Operating Characteristic
6%
Multivariate Logistic Regression Analysis
6%
Depression
6%
Brain Ischemia
6%
Adverse Event
6%
Severe Acute Respiratory Syndrome
6%
Correlation Coefficient
6%
Hyperlipidemia
6%
Body Composition
6%
Injury Severity
6%
International Classification of Functioning, Disability and Health
6%
Shared Decision-Making
5%
Embase
5%
Internal Consistency
5%
Placebo
5%
Chronic Disease
5%
Blood Pressure
5%
Test Retest Reliability
5%
Non Insulin Dependent Diabetes Mellitus
5%
Effect Size
5%
Rheumatoid Arthritis
5%
Hemodialysis
5%
Proportional Hazards Model
5%
Population
5%
Pregnancy Outcome
5%
Low Birth Weight
5%